Freshpet (FRPT) 10-Q 5 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 01, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Trading Symbol	FRPT
Entity Registrant Name	FRESHPET, INC.
Entity Central Index Key	0001611647
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		40,266,181
Entity Shell Company	false
Entity File Number	001-36729
Entity Tax Identification Number	20-1884894
Entity Address, Address Line One	400 Plaza Drive
Entity Address, Address Line Two	1st Floor
Entity Address, City or Town	Secaucus
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07094
City Area Code	201
Local Phone Number	520-4000
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false

CONSOLIDATED BALANCE SHEETS (Un

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)		Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents		$ 149,486,159	$ 9,471,676
Short-term investments		20,000,000
Accounts receivable, net of allowance for doubtful accounts		20,295,397	18,580,840
Inventories, net		16,005,370	12,542,269
Prepaid expenses		2,998,336	3,275,992
Other current assets(1)	[1]	10,720,781	10,452,990
Total Current Assets		219,506,043	54,323,767
Property, plant and equipment, net		195,607,774	165,287,597
Deposits on equipment		4,298,520	3,600,931
Operating lease right of use assets		8,846,194	9,154,234
Other assets		3,708,158	3,759,058
Total Assets		431,966,689	236,125,587
CURRENT LIABILITIES:
Accounts payable		20,420,592	18,667,729
Accrued expenses(1)	[1]	20,440,468	22,132,928
Current operating lease liabilities		1,241,168	1,185,058
Total Current Liabilities		42,102,228	41,985,715
Long term debt			54,466,099
Long term operating lease liabilities		8,069,160	8,409,252
Total Liabilities		50,171,388	104,861,066
STOCKHOLDERS' EQUITY:
Common stock — voting, $0.001 par value, 200,000,000 shares authorized, 40,271,411 issued and 40,257,242 outstanding on March 31, 2020, and 36,162,433 issued and 36,148,264 outstanding on December 31, 2019		40,271	36,162
Additional paid-in capital		588,357,121	334,299,172
Accumulated deficit		(206,325,650)	(202,735,417)
Accumulated other comprehensive income		(20,215)	(79,170)
Treasury stock, at cost — 14,169 shares on March 31, 2020 and on December 31, 2019		(256,226)	(256,226)
Total Stockholders' Equity		381,795,301	131,264,521
Total Liabilities and Stockholders' Equity		$ 431,966,689	$ 236,125,587
[1]	See Note 10 for additional information.

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	40,271,411	36,162,433
Common stock, shares outstanding	40,257,242	36,148,264
Treasury stock, at cost, shares	14,169	14,169

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
NET SALES	$ 70,097,805	$ 54,792,202
COST OF GOODS SOLD	38,308,179	28,877,221
GROSS PROFIT	31,789,626	25,914,981
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES	34,675,943	29,232,250
LOSS FROM OPERATIONS	(2,886,317)	(3,317,269)
OTHER INCOME/(EXPENSES):
Other Income/(Expenses), net	21,518	17,295
Interest Expense	(703,834)	(102,776)
Other Income/(Expenses), Total	(682,316)	(85,481)
LOSS BEFORE INCOME TAXES	(3,568,633)	(3,402,750)
INCOME TAX EXPENSE	21,600	19,250
LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(3,590,233)	(3,422,000)
OTHER COMPREHENSIVE INCOME (LOSS):
Change in foreign currency translation	58,955	91,047
TOTAL OTHER COMPREHENSIVE INCOME	58,955	91,047
TOTAL COMPREHENSIVE LOSS	$ (3,531,278)	$ (3,330,953)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC	$ (0.10)	$ (0.10)
-DILUTED	$ (0.10)	$ (0.10)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING USED IN COMPUTING NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC	37,443,758	35,668,323
-DILUTED	37,443,758	35,668,323

CHANGES TO STATEMENTS OF STOCKH

CHANGES TO STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock - Voting	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Treasury Stock
BALANCES at Dec. 31, 2018	$ 121,474,475	$ 35,556	$ 323,079,437	$ (201,352,682)	$ (31,610)	$ (256,226)
Shares, Outstanding at Dec. 31, 2018		35,556,595				14,169
Exercise of options to purchase common stock	1,791,668	$ 248	1,791,420
Exercise of options to purchase common stock, shares		248,195
Issuance of restricted stock units	(673,774)	$ 62	(673,836)
Issuance of restricted stock units, shares		61,532
Share-based compensation expense	1,260,126		1,260,126
Foreign Currency Translation	91,047				91,047
Net income (loss)	(3,422,000)			(3,422,000)
BALANCES at Mar. 31, 2019	120,521,542	$ 35,866	325,457,147	(204,774,682)	59,437	$ (256,226)
Shares, Outstanding at Mar. 31, 2019		35,866,322				14,169
BALANCES at Dec. 31, 2019	131,264,521	$ 36,162	334,299,172	(202,735,417)	(79,170)	$ (256,226)
Shares, Outstanding at Dec. 31, 2019		36,162,433				14,169
Exercise of options to purchase common stock	402,556	$ 44	402,512
Exercise of options to purchase common stock, shares		44,156
Issuance of restricted stock units	(644,599)	$ 65	(644,664)
Issuance of restricted stock units, shares		64,823
Share-based compensation expense	2,241,847		2,241,847
Shares issued in primary offering	252,062,254	$ 4,000	252,058,254
Shares issued in primary offering, shares		3,999,999
Foreign Currency Translation	58,955				58,955
Net income (loss)	(3,590,233)			(3,590,233)
BALANCES at Mar. 31, 2020	$ 381,795,301	$ 40,271	$ 588,357,121	$ (206,325,650)	$ (20,215)	$ (256,226)
Shares, Outstanding at Mar. 31, 2020		40,271,411				14,169

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,590,233)	$ (3,422,000)
Adjustments to reconcile net loss to net cash flows provided by operating activities:
Provision for loss/(gains) on accounts receivable	90,712	28,778
Loss on disposal of equipment	1,662	8,028
Share-based compensation	2,178,214	1,200,336
Inventory obsolescence	117,937	10,238
Depreciation and amortization	4,453,031	3,720,091
Amortization of deferred financing costs and loan discount	625,299	28,775
Changes in operating assets and liabilities:
Accounts receivable	(1,805,269)	(5,010,252)
Inventories	(3,581,038)	(1,802,222)
Prepaid expenses and other current assets	9,865	(929,849)
Operating lease right of use	308,040	241,785
Other assets	11,786	(36,010)
Accounts payable	655,688	2,555,681
Accrued expenses	(1,692,460)	(832,986)
Other lease liabilities	(283,982)	(217,469)
Net cash flows used in operating activities	(2,500,748)	(4,457,076)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term investments	(20,000,000)
Acquisitions of property, plant and equipment, software and deposits on equipment	(34,237,980)	(10,453,923)
Net cash flows used in investing activities	(54,237,980)	(10,453,923)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from common shares issued in primary offering, net of issuance cost	252,062,254
Proceeds from exercise of options to purchase common stock	402,556	1,791,668
Tax withholdings related to net shares settlements of restricted stock units	(644,599)	(673,774)
Proceeds from borrowings under Credit Facilities	20,933,000	10,000,000
Repayment of borrowings under Credit Facilities	(76,000,000)
Net cash flows provided by financing activities	196,753,211	11,117,894
NET CHANGE IN CASH AND CASH EQUIVALENTS	140,014,483	(3,793,105)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	9,471,676	7,554,388
CASH AND CASH EQUIVALENTS, END OF PERIOD	149,486,159	3,761,283
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	766,950	29,717
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Property, plant and equipment purchases in accounts payable	$ 8,671,690	463,546
Non-cash acquisitions of property, plant and equipment		$ 1,749,901

Nature of the Business and Summ

Nature of the Business and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Nature of the Business and Summary of Significant Accounting Policies	Note 1 – Nature of the Business and Summary of Significant Accounting Policies: Nature of the Business – Freshpet, Inc. (hereafter referred to as “Freshpet” the “Company”, “we” or “our”), a Delaware corporation, manufactures and markets natural fresh meals and treats for dogs and cats. The Company’s products are distributed throughout the United States and other international markets, into major retail classes including Grocery (including online), Mass and Club, Pet Specialty, and Natural retail. Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The unaudited consolidated financial statements include the accounts of the Company as well as the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The interim unaudited consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2020, the results of its operations and changes to stockholders’ equity for the three months ended March 31, 2020 and 2019, and its cash flows for the three months ended March 31, 2020 and 2019. The results for the three months ended March 31, 2020 are not necessarily indicative of results to be expected for the year ending December 31, 2020, or any other interim periods, or any future year or period. Certain amounts that appear in this report may not add up because of differences due to rounding. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 of Part II, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2019. Estimates and Uncertainties – The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates. Fair Value of Financial Instruments – Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: • Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. • Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. • Level 3 – Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments. As of March 31, 2020, the Company only maintained Level 1 assets and liabilities. Short-Term Investments – The Company holds interest-bearing certificates of deposits with financial institutions with maturities ranging from three months to one year. Certificates of deposit are classified as short-term investments and interest is recorded as other income. Restricted Stock Tax Withholdings – To meet payroll tax withholdings obligations arising from the vesting of restricted share units, the Company withheld 10,077 shares totaling $0.7 million, for the three month period ended March 31, 2019. Shares of common stock withheld for tax withholdings do not reduce the Company’s total share repurchase authority. Debt Issuance Cost – During 2019, the Company incurred $1.1 million of fees associated with the debt modification, of which $0.7 million were paid to the creditor. Further, the Company noted that $0.7 million of the fees were related to the Draw Term Loan with the remaining balance relating to the Revolving Loan Facility. The Company’s policy is to record the debt issuance cost related to the Draw Term Loan, net of debt, for the portion of the Draw Term Loan that is outstanding, with the remaining amount recorded within assets. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related fees. As of March 31, 2020, there was $0.5 million of debt issuance cost that were recorded to other assets and less than $0.1 million was recorded to other current assets. The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan, and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan. Information about the Company’s net sales by class of retailer is as follows: Three Months Ended March 31, 2020 2019 Grocery (including Online), Mass and Club $ 60,818,851 $ 45,707,897 Pet Specialty and Natural 9,278,954 9,084,305 Net Sales $ 70,097,805 $ 54,792,202 Recently Issued Accounting Standards In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-13, Financial Instruments— Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The reported results for the three months ended March 31, 2020 reflect the application of ASU 2016-13. The application of the update did not have a material impact to our reserve for accounts receivable. Please see the description of the Company’s “Trade accounts receivable” accounting policy below. Trade accounts receivable – The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Inventories	Note 2 – Inventories: March 31, December 31, 2020 2019 Raw Materials and Work in Process $ 4,184,814 $ 4,453,498 Packaging Components Material 1,869,166 1,419,155 Finished Goods 10,092,896 6,842,359 16,146,876 12,715,012 Reserve for Obsolete Inventory (141,506 ) (172,743 ) $ 16,005,370 $ 12,542,269

Property, Plant and Equipment

Property, Plant and Equipment	3 Months Ended
	Mar. 31, 2020
Property Plant And Equipment [Abstract]
Property, Plant and Equipment	Note 3 – Property, Plant and Equipment: March 31, December 31, 2020 2019 Refrigeration Equipment $ 102,591,520 $ 97,568,137 Machinery and Equipment 68,781,746 54,274,118 Building, Land, and Improvements 25,621,495 25,621,495 Furniture and Office Equipment 4,969,901 4,931,703 Leasehold Improvements 395,241 395,241 Automotive Equipment 309,137 309,137 Construction in Progress 73,702,188 58,587,375 276,371,228 241,687,206 Less: Accumulated Depreciation (80,763,454 ) (76,399,609 ) $ 195,607,774 $ 165,287,597 Depreciation expense related to property, plant and equipment totaled $4,372,792 for the three months ended March 31, 2020, of which $1,743,657 was recorded to cost of goods sold for the three months ended March 31, 2020, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense . Depreciation expense related to property, plant and equipment totaled $3,643,492 for the three months ended March 31, 2019, of which $1,566,088 was recorded to cost of goods sold for the three months ended March 31, 2019, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense.

Accrued Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2020
Payables And Accruals [Abstract]
Accrued Expenses	Note 4 – Accrued Expenses: March 31, December 31, 2020 2019 Legal Contingency (1) 10,310,000 10,100,000 Accrued Compensation and Employee Related Costs 4,033,898 6,390,692 Accrued Chiller Cost 1,548,752 1,576,214 Accrued Customer Consideration 735,172 635,399 Accrued Freight 726,381 702,673 Accrued Production Expenses 1,801,527 413,550 Accrued Marketing 595,376 1,187,885 Other Accrued Expenses 689,362 1,126,515 $ 20,440,468 $ 22,132,928 (1) See Note 10 for additional information.

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Note 5 – Debt: On May 15, 2019, the Company entered into the Fourth Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”), which amended and restated in full the Company’s Third Amended and Restated Loan and Security Agreement, dated as of September 21, 2017. The Loan Agreement provided for a $90 million senior secured credit facility (the “Credit Facility”), encompassing a $55.0 million delayed draw term loan facility (the “Draw Facility”) and a $35.0 million revolving loan facility (the “Revolving Loan Facility”) The Credit Facility was scheduled to mature on May 15, 2024 and borrowings thereunder accrued interest at variable rates depending on the Company’s election, either at a base rate or at LIBOR, in each case, plus an applicable margin. Subject to the Company’s leverage ratio, the applicable margin varied between 0.50% and 1.00% for base rate loans and 1.50% and 2.00% for LIBOR loans. Upon closing the Credit Facility, the Company borrowed $15.0 million under the Revolving Loan Facility, which left $20.0 million of availability. The Company had the option to borrow term loans under the Draw Facility (“Draw Term Loans”) until May 15, 2021, subject to certain conditions. Borrowings under the Credit Facility were secured by substantially all of the Company’s and certain of its subsidiaries’ assets. The Loan Agreement required compliance with various covenants customary for agreements of this type, including financial covenants and negative covenants that limit, among other things, the Company’s ability to incur additional debt, create or incur liens, engage in mergers or consolidations, sell, transfer or otherwise dispose of assets, make voluntary prepayments to subordinated debt, permit a change of control, pay dividends or distributions, make investments, and enter into certain transactions with affiliates. The Loan Agreement also included events of default customary for agreements of this type. As of March 31, 2020, the Company had no debt outstanding under the Credit Facilities. During the first quarter of 2020, borrowings under the Credit Facilities totaled $20.9 million that consisted of $13.9 million related to Draw Term Loans, net of unamortized debt issuance cost of less than $0.1 million, and $7.0 million related to the Revolving Loan Facility. borrowings under the Credit Facilities totaled $54.5 million at December 31, 2019, of which $40.5 million net of unamortized debt issuance cost of $0.6 million, related to the Draw Term Loans and $14.0 million related to the Revolving Loan Facility. Interest expense and fees totaled $0.7 million for the three months ended March 31, 2020, of which $0.6 million was related to the recognition of debt issuance fees due to the repayment of the Draw Term Loan. Interest expense and fees totaled $0.1 million for the three months ended March 31, 2019. In 2019, the Company incurred $1.1 million of debt issuance cost upon execution of the Credit Facility. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related debt issuance fees that w ere recognized as interest expense . As of March 3 1 , 20 20 , $ million of the remaining debt issuance cost was recorded to other assets and less than $ million was recorded to other current assets .

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Note 6– Leases: We have various noncancellable lease agreements for office and warehouse space, as well as office equipment, with original remaining lease terms of two years to nine years, some of which include an option to extend the lease term for up to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and associated potential option payments are excluded from lease payments. The Company’s leases generally do not include termination options for either party to the lease or restrictive financial or other covenants. Weighted-average remaining lease term (in years) and discount rate related to operating leases were as follows: Weighted-average remaining lease term 5.99 Weighted-average discount rate 6.14 % As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the date of adoption to determine the present value of lease payments. Maturities of lease liabilities under noncancellable operating leases as of March 31, 2020 were as follows: March 31, 2020 2020 (a) 1,319,802 2021 1,768,626 2022 1,763,787 2023 1,802,007 2024 1,511,214 2024 and beyond 2,786,004 Total lease payments 10,951,440 Less: Imputed interest (1,641,112 ) Present value of lease liabilities $ 9,310,328 (a) Excluding the three months ended March 31, 2020. A summary of rent expense for the three months ended March 31, 2020 and 2019 was as follows: For the Three Months Ended March 31, 2020 2019 Operating lease cost $ 452,155 $ 256,882 Supplemental cash flow information and non-cash activity relating to operating leases are as follows: For the Three Months Ended March 31, 2020 2019 Operating cash flow information: Cash paid for amounts included in the measurement of lease liabilities $ 283,982 $ 246,735

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Equity Incentive Plans	Note 7 – Equity Incentive Plans: Total compensation cost for share-based payments recognized for the three months ended March 31, 2020 and 2019 is $2,241,847 and $ 1,260,126 2010 Stock Plan — The outstanding options are time-based (vest between two and four years). At March 31, 2020, there were zero shares available for grant as the 2010 Plan is frozen . The total number of unexercised options for the 2010 Plan is 256,890. 2014 Omnibus Incentive Plan —In November 2014, the Company approved the 2014 Omnibus Incentive Plan (the “2014 Plan”). Under the 2014 Plan, 2,644,133 shares of common stock may be issued or used for reference purposes as awards granted. These awards may be in the form of stock options, stock appreciation rights, restricted stock, as well as other stock-based and cash-based awards. At March 31, 2020, the awards granted were either time-based, performance-based (vest when performance targets are met, as defined in the stock option grant agreement), or restricted stock units (employee RSUs vest over three years or cliff vest (as defined in the restricted stock agreement) and non-employee director RSUs vest over one year). The total number of unexercised options and RSUs for the 2014 Plan is 2,644,133. At March 31, 2020, there were 1,457,834 shares of common stock available to be issued or used for reference purposes under the 2014 Plan. NASDAQ Marketplace Rules Inducement Award —During fiscal year 2016 and the first quarter of 2020, share-based awards were granted to the Company’s Chief Executive Officer and the Executive Vice President of Finance, respectively, as an inducement under the NASDAQ Marketplace Rules, and therefore outside of any Plan. Under the terms of the agreement, the grant is governed as if issued under the 2014 Omnibus Plan. As of March 31, 2020, the awards granted were time-based (cliff vest over four years) and performance-based (vest when performance targets are met, as defined in the stock option grant agreement). Service Period Stock Options The following table includes activity related to outstanding service period stock options during the three months ended March 31, 2020. Service Period Stock Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,359,990 $ 11.50 Granted 15,000 60.10 Exercised (44,156 ) 9.11 Forfeited (357 ) 11.00 Outstanding at March 31, 2020 1,330,477 $ 12.13 Performance-Vested Stock Options The following table includes activity related to outstanding performance-vested stock options during the nine months ended March 31, 2020. Performance Based Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,372,819 $ 18.31 Granted — — Exercised — — Forfeited — — Outstanding at March 31, 2020 1,372,819 $ 18.31 As of March 31, 2020, 1,303,361 performance-vested stock options at a weighted average exercise price of $18.50 have performance metrics that are probable of achievement. These shares are included in share-based compensation costs for the three months ended March 31, 2020. Restricted Stock Units The following table includes activity related to outstanding restricted stock units during the three months ended March 31, 2020. Restricted Stock Units Shares Weighted-Average Grant-Date Fair Value Per Unit Outstanding at December 31, 2019 240,229 $ 29.07 Granted 5,280 62.88 Issued upon vesting (32,727 ) 17.56 Forfeited (604 ) 32.83 Outstanding at March 31, 2020 212,178 $ 31.68

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Shareholder	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Shareholder	Note 8 – Net Loss Per Share Attributable to Common Shareholder: Basic net loss per share of common stock is calculated by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed by giving effect to all potentially dilutive securities. For the three months ended March 31, 2020 and 2019, there were no adjustments between net loss and net loss attributable to common stockholders. The potentially dilutive securities are as follows: Three Months Ended March 31, 2020 2019 Service Period Stock Options 1,355,853 1,686,048 Restricted Stock Units 241,582 249,252 Performance Stock Options 34,482 59,693 Total 1,631,917 1,994,993 For the three months ended March 31, 2020 and 2019, diluted net loss per share of common stock is the same as basic net loss per share of common stock, due to the fact that potentially dilutive securities would have an antidilutive effect as the Company incurred a net loss during such periods.

Concentrations

Concentrations	3 Months Ended
	Mar. 31, 2020
Risks And Uncertainties [Abstract]
Concentrations	Note 9 – Concentrations: Concentration of Credit Risk —The Company maintains its cash balances in financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 each. At times, such balances may be in excess of the FDIC insurance limit.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10 – Commitments and Contingencies: A securities lawsuit, Curran v. Freshpet, Inc. et al, Docket No. 2:16-cv-02263, was instituted on April 21, 2016 in the United States District Court for the District of New Jersey against the Company and certain of the Company’s current and former executive officers and directors on behalf of certain purchasers of our common stock. The plaintiffs sought to recover damages for investors under the federal securities laws. On October 3, 2019, the parties filed with the District Court a motion for preliminary approval of settlement that attached the parties’ stipulation of settlement and a proposed order. The settlement funds due, held in escrow, were paid by the Company’s insurers, and the District Court approved the Final Judgment and Order of Dismissal with Prejudice on March 11, 2020 with a 30 day option to appeal. As of March 31, 2020, the Company accrued for an estimated probable loss of $10.1 million, which represents the settlement amount and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $10.1 within other current assets. There was no appeal taken within 30 days from the entry of the Judgment. The Judgment was Effective April 10, 2020. A shareholder derivative lawsuit, Meldon v. Freshpet, Inc. et al, Docket No. 2:18-cv-10166, was instituted June 5, 2018 in the United States District Court for the District of New Jersey against us and certain of our current and former executive officers and directors on behalf of certain holders of our common stock. We were served with a copy of the complaint in June 2018. The plaintiffs seek to recover damages for investors based on state law claims (alleged breaches of fiduciary duty, waste, and unjust enrichment) in connection with the alleged violations of federal securities laws alleged in the Curran action. On April 3, 2019, the Court granted a stay of the Meldon case pending (i) the close of expert discovery in the Curran action or (ii) the dismissal with prejudice of the Curran action. The parties then entered into settlement discussions, after which the parties reached an agreement in principle to settle the case based on the Company’s commitment to continue certain governance practices. The parties also reached agreement on attorneys’ fees. The settlement is subject to court approval. All parties believe that the agreement in principle to settle the dispute is in their respective best interests in order to avoid the risk, uncertainty, and costs associated with litigation. The parties are in the process of finalizing the settlement documents for submission to the District Court. As of March 31,2020, the Company accrued for an estimated probable loss of $0.2 million, which represents the proposed settlement and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $0.2 million within other current assets

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 11 – Subsequent Events: The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued for recognitions or disclosures and no events have occurred that require disclosure, except for the following: On April 17, 2020 the Company amended its senior secured credit facility (the “New Credit Facility”). This New Credit Facility of $165.0 million, includes a $130.0 million delayed draw term loan facility and a $35.0 million revolving loan facility. The New Credit Facilities replaces the Company’s prior $55.0 million delayed draw term loan facility and $35.0 million revolving loan facility. The New Credit Facility will mature on April 17, 2025. Based upon further evaluation, the Company did not identify any additional recognized or unrecognized subsequent events that have required adjustment or disclosure in the financial statements.

Nature of the Business and Su_2

Nature of the Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Nature of the Business	Nature of the Business – Freshpet, Inc. (hereafter referred to as “Freshpet” the “Company”, “we” or “our”), a Delaware corporation, manufactures and markets natural fresh meals and treats for dogs and cats. The Company’s products are distributed throughout the United States and other international markets, into major retail classes including Grocery (including online), Mass and Club, Pet Specialty, and Natural retail.
Basis of Presentation	Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The unaudited consolidated financial statements include the accounts of the Company as well as the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The interim unaudited consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2020, the results of its operations and changes to stockholders’ equity for the three months ended March 31, 2020 and 2019, and its cash flows for the three months ended March 31, 2020 and 2019. The results for the three months ended March 31, 2020 are not necessarily indicative of results to be expected for the year ending December 31, 2020, or any other interim periods, or any future year or period. Certain amounts that appear in this report may not add up because of differences due to rounding. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 of Part II, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2019.
Estimates and Uncertainties	Estimates and Uncertainties – The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates. Fair Value of Financial Instruments – Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: • Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. • Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. • Level 3 – Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments. As of March 31, 2020, the Company only maintained Level 1 assets and liabilities. Short-Term Investments – The Company holds interest-bearing certificates of deposits with financial institutions with maturities ranging from three months to one year. Certificates of deposit are classified as short-term investments and interest is recorded as other income. Restricted Stock Tax Withholdings – To meet payroll tax withholdings obligations arising from the vesting of restricted share units, the Company withheld 10,077 shares totaling $0.7 million, for the three month period ended March 31, 2019. Shares of common stock withheld for tax withholdings do not reduce the Company’s total share repurchase authority. Debt Issuance Cost – During 2019, the Company incurred $1.1 million of fees associated with the debt modification, of which $0.7 million were paid to the creditor. Further, the Company noted that $0.7 million of the fees were related to the Draw Term Loan with the remaining balance relating to the Revolving Loan Facility. The Company’s policy is to record the debt issuance cost related to the Draw Term Loan, net of debt, for the portion of the Draw Term Loan that is outstanding, with the remaining amount recorded within assets. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related fees. As of March 31, 2020, there was $0.5 million of debt issuance cost that were recorded to other assets and less than $0.1 million was recorded to other current assets. The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan, and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan. Information about the Company’s net sales by class of retailer is as follows: Three Months Ended March 31, 2020 2019 Grocery (including Online), Mass and Club $ 60,818,851 $ 45,707,897 Pet Specialty and Natural 9,278,954 9,084,305 Net Sales $ 70,097,805 $ 54,792,202
Recently Issued Accounting Standards	Recently Issued Accounting Standards In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-13, Financial Instruments— Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The reported results for the three months ended March 31, 2020 reflect the application of ASU 2016-13. The application of the update did not have a material impact to our reserve for accounts receivable. Please see the description of the Company’s “Trade accounts receivable” accounting policy below. Trade accounts receivable – The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

Nature of the Business and Su_3

Nature of the Business and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Information About Company's Net Sales By Class of Retailer	Information about the Company’s net sales by class of retailer is as follows: Three Months Ended March 31, 2020 2019 Grocery (including Online), Mass and Club $ 60,818,851 $ 45,707,897 Pet Specialty and Natural 9,278,954 9,084,305 Net Sales $ 70,097,805 $ 54,792,202

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Summary of Inventories	March 31, December 31, 2020 2019 Raw Materials and Work in Process $ 4,184,814 $ 4,453,498 Packaging Components Material 1,869,166 1,419,155 Finished Goods 10,092,896 6,842,359 16,146,876 12,715,012 Reserve for Obsolete Inventory (141,506 ) (172,743 ) $ 16,005,370 $ 12,542,269

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	3 Months Ended
	Mar. 31, 2020
Property Plant And Equipment [Abstract]
Summary of Property, Plant and Equipment, Net	March 31, December 31, 2020 2019 Refrigeration Equipment $ 102,591,520 $ 97,568,137 Machinery and Equipment 68,781,746 54,274,118 Building, Land, and Improvements 25,621,495 25,621,495 Furniture and Office Equipment 4,969,901 4,931,703 Leasehold Improvements 395,241 395,241 Automotive Equipment 309,137 309,137 Construction in Progress 73,702,188 58,587,375 276,371,228 241,687,206 Less: Accumulated Depreciation (80,763,454 ) (76,399,609 ) $ 195,607,774 $ 165,287,597

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2020
Payables And Accruals [Abstract]
Summary of Accrued Expenses	March 31, December 31, 2020 2019 Legal Contingency (1) 10,310,000 10,100,000 Accrued Compensation and Employee Related Costs 4,033,898 6,390,692 Accrued Chiller Cost 1,548,752 1,576,214 Accrued Customer Consideration 735,172 635,399 Accrued Freight 726,381 702,673 Accrued Production Expenses 1,801,527 413,550 Accrued Marketing 595,376 1,187,885 Other Accrued Expenses 689,362 1,126,515 $ 20,440,468 $ 22,132,928 (1) See Note 10 for additional information.

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Weighted Average Remaining Lease Term And Discount Rate Related To Operating Leases	Weighted-average remaining lease term (in years) and discount rate related to operating leases were as follows: Weighted-average remaining lease term 5.99 Weighted-average discount rate 6.14 %
Maturities of Lease Liabilities Under Noncancelable Operating Leases	Maturities of lease liabilities under noncancellable operating leases as of March 31, 2020 were as follows: March 31, 2020 2020 (a) 1,319,802 2021 1,768,626 2022 1,763,787 2023 1,802,007 2024 1,511,214 2024 and beyond 2,786,004 Total lease payments 10,951,440 Less: Imputed interest (1,641,112 ) Present value of lease liabilities $ 9,310,328 (a) Excluding the three months ended March 31, 2020.
Summary of Rent Expense	A summary of rent expense for the three months ended March 31, 2020 and 2019 was as follows: For the Three Months Ended March 31, 2020 2019 Operating lease cost $ 452,155 $ 256,882
Supplemental Cash Flow Information And Non-cash Activity Relating To Operating Leases	Supplemental cash flow information and non-cash activity relating to operating leases are as follows: For the Three Months Ended March 31, 2020 2019 Operating cash flow information: Cash paid for amounts included in the measurement of lease liabilities $ 283,982 $ 246,735

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2020
Service Period Stock Options
Summary of Activity Related to Outstanding Stock Options	The following table includes activity related to outstanding service period stock options during the three months ended March 31, 2020. Service Period Stock Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,359,990 $ 11.50 Granted 15,000 60.10 Exercised (44,156 ) 9.11 Forfeited (357 ) 11.00 Outstanding at March 31, 2020 1,330,477 $ 12.13
Performance-Vested Stock Options
Summary of Activity Related to Outstanding Stock Options	The following table includes activity related to outstanding performance-vested stock options during the nine months ended March 31, 2020. Performance Based Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,372,819 $ 18.31 Granted — — Exercised — — Forfeited — — Outstanding at March 31, 2020 1,372,819 $ 18.31
Restricted Stock Units
Summary of Activity Related to Outstanding Stock Options	The following table includes activity related to outstanding restricted stock units during the three months ended March 31, 2020. Restricted Stock Units Shares Weighted-Average Grant-Date Fair Value Per Unit Outstanding at December 31, 2019 240,229 $ 29.07 Granted 5,280 62.88 Issued upon vesting (32,727 ) 17.56 Forfeited (604 ) 32.83 Outstanding at March 31, 2020 212,178 $ 31.68

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Shareholder (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Potentially Dilutive Securities	The potentially dilutive securities are as follows: Three Months Ended March 31, 2020 2019 Service Period Stock Options 1,355,853 1,686,048 Restricted Stock Units 241,582 249,252 Performance Stock Options 34,482 59,693 Total 1,631,917 1,994,993

Nature of the Business and Su_4

Nature of the Business and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Payments related to tax withholding for share-based compensation	$ 644,599	$ 673,774
Shares paid for tax withholding for share based compensation		10,077
Fees associated with debt modification			$ 1,100,000
Term Loans
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Debt issuance fees write off	600,000
Revolving Credit Facility
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Payment of fees associated with debt modification			700,000
Other Assets
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Debt issuance cost recorded as net of debt outstanding	500,000
Maximum | Other Current Assets
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Debt issuance cost recorded as net of debt outstanding	$ 100,000
Creditor
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Payment of fees associated with debt modification			$ 700,000

Nature of the Business and Su_5

Nature of the Business and Summary of Significant Accounting Policies - Information About Company's Net Sales By Class of Retailer (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Net Sales	$ 70,097,805	$ 54,792,202
Grocery (including Online), Mass and Club
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Net Sales	60,818,851	45,707,897
Pet Specialty and Natural
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Net Sales	$ 9,278,954	$ 9,084,305

Inventories - Summary of Invent

Inventories - Summary of Inventories (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw Materials and Work in Process	$ 4,184,814	$ 4,453,498
Packaging Components Material	1,869,166	1,419,155
Finished Goods	10,092,896	6,842,359
Inventory gross	16,146,876	12,715,012
Reserve for Obsolete Inventory	(141,506)	(172,743)
Inventory net	$ 16,005,370	$ 12,542,269

Property, Plant and Equipment -

Property, Plant and Equipment - Summary of Property, Plant and Equipment, Net (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 276,371,228	$ 241,687,206
Less: Accumulated Depreciation	(80,763,454)	(76,399,609)
Property, plant and equipment, net	195,607,774	165,287,597
Refrigeration Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	102,591,520	97,568,137
Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	68,781,746	54,274,118
Building, Land, and Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	25,621,495	25,621,495
Furniture and Office Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	4,969,901	4,931,703
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	395,241	395,241
Automotive Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	309,137	309,137
Construction in Progress
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 73,702,188	$ 58,587,375

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Property, Plant and Equipment
Property Plant And Equipment [Line Items]
Depreciation expense	$ 4,372,792	$ 3,643,492
Product
Property Plant And Equipment [Line Items]
Cost of goods sold, depreciation and amortization	$ 1,743,657	$ 1,566,088

Accrued Expenses - Summary of A

Accrued Expenses - Summary of Accrued Expenses (Details) - USD ($)		Mar. 31, 2020	Dec. 31, 2019
Payables And Accruals [Abstract]
Legal Contingency		$ 10,310,000	$ 10,100,000
Accrued Compensation and Employee Related Costs		4,033,898	6,390,692
Accrued Chiller Cost		1,548,752	1,576,214
Accrued Customer Consideration		735,172	635,399
Accrued Freight		726,381	702,673
Accrued Production Expenses		1,801,527	413,550
Accrued Marketing		595,376	1,187,885
Other Accrued Expenses		689,362	1,126,515
Accrued expenses	[1]	$ 20,440,468	$ 22,132,928
[1]	See Note 10 for additional information.

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($)	May 15, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Debt Instrument [Line Items]
Borrowings under credit facilities		$ 20,933,000	$ 10,000,000
Debt outstanding under credit facilities		0
Debt outstanding		20,900,000		$ 54,500,000
Unamortized debt issuance cost				600,000
Interest expense and fees		700,000	$ 100,000
Other Assets
Debt Instrument [Line Items]
Financing costs capitalized		500,000
Term Loans
Debt Instrument [Line Items]
Debt outstanding		13,900,000		40,500,000
Amortization of debt issuance costs		600,000
Revolving Loan
Debt Instrument [Line Items]
Debt outstanding		7,000,000		14,000,000
Maximum
Debt Instrument [Line Items]
Unamortized debt issuance cost		100,000
Maximum | Other Current Assets
Debt Instrument [Line Items]
Financing costs capitalized		100,000
Credit Facility
Debt Instrument [Line Items]
Debt instrument, face amount	$ 90,000,000
Line of credit facility, maturity date	May 15, 2024
Amortization of debt issuance costs				$ 1,100,000
Credit Facility | Term Loans
Debt Instrument [Line Items]
Amortization of debt issuance costs		600,000
Credit Facility | Term Loans | Other Assets
Debt Instrument [Line Items]
Financing costs capitalized		500,000
Credit Facility | Maximum
Debt Instrument [Line Items]
Increase in credit facility	$ 75,000,000
Credit Facility | Maximum | Term Loans | Other Current Assets
Debt Instrument [Line Items]
Financing costs capitalized		$ 100,000
Credit Facility | Maximum | Base Rate
Debt Instrument [Line Items]
Line of credit facility, applicable margin	1.00%
Credit Facility | Maximum | LIBOR
Debt Instrument [Line Items]
Line of credit facility, applicable margin	2.00%
Credit Facility | Minimum | Base Rate
Debt Instrument [Line Items]
Line of credit facility, applicable margin	0.50%
Credit Facility | Minimum | LIBOR
Debt Instrument [Line Items]
Line of credit facility, applicable margin	1.50%
Delayed Draw Facility
Debt Instrument [Line Items]
Debt instrument, face amount	$ 55,000,000
Revolving Loan Facility
Debt Instrument [Line Items]
Debt instrument, face amount	35,000,000
Borrowings under credit facilities	15,000,000
Line of credit facility, remaining borrowing capacity	$ 20,000,000

Leases - Additional Information

Leases - Additional Information (Details)	3 Months Ended
	Mar. 31, 2020
Lessee Lease Description [Line Items]
Operating lease, renewal term	5 years
Operating lease, existence of option to extend	true
Minimum
Lessee Lease Description [Line Items]
Operating lease remaining lease term	2 years
Maximum
Lessee Lease Description [Line Items]
Operating lease remaining lease term	9 years

Leases - Weighted Average Remai

Leases - Weighted Average Remaining Lease Term And Discount Rate Related To Operating Leases (Details)	Mar. 31, 2020
Leases [Abstract]
Weighted-average remaining lease term	5 years 11 months 26 days
Weighted-average discount rate	6.14%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities Under Noncancelable Operating Leases (Details)	Mar. 31, 2020USD ($)
Leases [Abstract]
2020	$ 1,319,802
2021	1,768,626
2022	1,763,787
2023	1,802,007
2024	1,511,214
2024 and beyond	2,786,004
Total lease payments	10,951,440
Less: Imputed interest	(1,641,112)
Present value of lease liabilities	$ 9,310,328

Leases - Summary of Rent Expens

Leases - Summary of Rent Expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease cost	$ 452,155	$ 256,882

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information And Non-cash Activity Relating To Operating Leases (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$ 283,982	$ 246,735

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Nov. 30, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation	$ 2,241,847	$ 1,260,126
Service Period Stock Options | Chief Executive Officer and Executive Vice President of Finance
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	4 years
Performance-Vested Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Performance-vested stock options	1,303,361
Performance-vested stock options, weighted average exercise price	$ 18.50
2010 Stock Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options, available for grant	0
Total number of unexercised options	256,890
2010 Stock Plan | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	2 years
2010 Stock Plan | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	4 years
2014 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options, available for grant	1,457,834		2,644,133
2014 Omnibus Incentive Plan | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total number of unexercised options	2,644,133
2014 Omnibus Incentive Plan | Restricted Stock Units | Employee
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	3 years
2014 Omnibus Incentive Plan | Restricted Stock Units | Non-employee Director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	1 year

Equity Incentive Plans - Summar

Equity Incentive Plans - Summary of Activity Related to Outstanding Stock Options (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Service Period Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Outstanding Beginning Balance | shares	1,359,990
Shares, Granted | shares	15,000
Shares, Exercised | shares	(44,156)
Shares, Forfeited | shares	(357)
Shares, Outstanding Ending Balance | shares	1,330,477
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares	$ 11.50
Weighted Average Exercise Price, Granted | $ / shares	60.10
Weighted Average Exercise Price, Exercised | $ / shares	9.11
Weighted Average Exercise Price, Forfeited | $ / shares	11
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	$ 12.13
Performance-Vested Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Outstanding Beginning Balance | shares	1,372,819
Shares, Outstanding Ending Balance | shares	1,372,819
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares	$ 18.31
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	$ 18.31
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Outstanding Beginning Balance | shares	240,229
Shares, Granted | shares	5,280
Shares, Issued upon vesting | shares	(32,727)
Shares, Forfeited | shares	(604)
Shares, Outstanding Ending Balance | shares	212,178
Weighted-Average Grant-Date Fair Value Per Unit, Outstanding Beginning Balance | $ / shares	$ 29.07
Weighted-Average Grant-Date Fair Value Per Unit, Granted | $ / shares	62.88
Weighted-Average Grant-Date Fair Value Per Unit, Issued Upon Vesting | $ / shares	17.56
Weighted-Average Grant-Date Fair Value Per Unit, Forfeited | $ / shares	32.83
Weighted-Average Grant-Date Fair Value Per Unit, Outstanding Ending Balance | $ / shares	$ 31.68

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Shareholder - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Adjustments between net loss and net loss attributable to common stockholders	$ 0	$ 0

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Shareholder - Schedule of Potentially Dilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	1,631,917	1,994,993
Service Period Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	1,355,853	1,686,048
Restricted Stock Units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	241,582	249,252
Performance Shares
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	34,482	59,693

Concentrations - Additional Inf

Concentrations - Additional Information (Details)	Mar. 31, 2020USD ($)
Maximum
Concentration Risk [Line Items]
Cash, FDIC insured amount	$ 250,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	Mar. 11, 2020	Mar. 31, 2020	Dec. 31, 2019
Commitments And Contingencies [Line Items]
Legal Contingency		$ 10,310,000	$ 10,100,000
Curran v. Freshpet, Inc.
Commitments And Contingencies [Line Items]
Legal Contingency		10,100,000
Option to appeal period	30 days
Curran v. Freshpet, Inc. | Other Current Assets
Commitments And Contingencies [Line Items]
Gain Contingency		10,100,000
Meldon v. Freshpet, Inc. | Pending Litigation
Commitments And Contingencies [Line Items]
Legal Contingency		200,000
Meldon v. Freshpet, Inc. | Other Current Assets | Pending Litigation
Commitments And Contingencies [Line Items]
Gain Contingency		$ 200,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($)	Apr. 17, 2020	May 15, 2019
Delayed Draw Facility
Subsequent Event [Line Items]
Debt instrument, face amount		$ 55,000,000
Revolving Loan Facility
Subsequent Event [Line Items]
Debt instrument, face amount		$ 35,000,000
Subsequent Event | New Credit Facility
Subsequent Event [Line Items]
Debt instrument, face amount	$ 165,000,000
Line of credit facility, maturity date	Apr. 17, 2025
Subsequent Event | Delayed Draw Facility
Subsequent Event [Line Items]
Debt instrument, face amount	$ 130,000,000
Subsequent Event | Revolving Loan Facility
Subsequent Event [Line Items]
Debt instrument, face amount	$ 35,000,000